peptides for adrenal support FAQ

Skip peptide protocols entirely and consult an endocrinologist. Low cortisol at all timepoints (<5 ng/mL waking, <1 ng/mL throughout the day) suggests primary adrenal insufficiency or secondary insufficiency from pituitary dysfunction. Neither responds to peptides that work by modulating existing cortisol output. True adrenal insufficiency requires hydrocortisone replacement, not HPA axis modulators.

Expect this. It's a documented rebound effect. When CRH signaling is chronically elevated, the hypothalamus has downregulated its own feedback receptors. Introducing T-reg cytokines that lower CRH initially disinhibits those receptors, causing a brief 5–7 day period where cortisol may spike 10–15% above baseline before dropping. This resolves without intervention and doesn't indicate protocol failure.

Cortisol modulation is necessary but not sufficient for resolving chronic stress symptomatology. If salivary cortisol normalizes but fatigue, sleep disruption, or cognitive symptoms persist, the issue may be downstream. Mitochondrial dysfunction, neurotransmitter depletion, or tissue-level insulin resistance. Peptides like Cerebrolysin address neuroplasticity pathways separately from HPA modulation.

Standard serum cortisol or even salivary four-point testing often misses HPA axis dysfunction because total cortisol output can remain within reference range while rhythm flattens or inverts. The cortisol awakening response (CAR). The 50–75% spike that should occur within 30 minutes of waking. Is a more sensitive marker and isn't captured by standard panels. If your subjective symptoms (fatigue, poor stress tolerance, sleep disruption) persist despite 'normal' results, consider whether you're measuring the right thing before starting peptides. Semax and Selank target rhythm and feedback regulation, not absolute cortisol levels.

This pattern suggests impaired cortisol rhythm rather than total output deficiency. Semax is the primary candidate because it restores hippocampal glucocorticoid receptor density, which governs the negative feedback loop that should taper cortisol after the morning peak. Dosing 300–600mcg intranasally in the morning targets the mechanism without suppressing the cortisol awakening response you still need. Thymalin addresses this pattern only if inflammation is driving the dysregulation (elevated CRP, autoimmune markers). Otherwise, you're treating the wrong pathway.

Ashwagandha reduces cortisol by 14–27% in clinical trials through mechanisms that aren't fully characterized but likely involve GABAergic modulation and 5-HT receptor effects. Combining ashwagandha with Selank. Which also acts on GABA pathways. May produce additive suppression and risk overcorrection, especially if your baseline cortisol isn't truly elevated. We've seen this pattern in researchers stacking multiple 'stress support' compounds without tracking biomarkers. If you're using adaptogens, choose Thymalin or Semax as your peptide option. They target immune and feedback mechanisms ashwagandha doesn't touch.